Andrew Donald Nash

USPTO Granted Patents = 29 (Patent Applications = 2)

CIPO Patents = 7

EPO Patents = 13 (Patent Applications = 6)

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 72(Granted Patents)

Location History:

Northcote, AU (2007)
Victoria, AU (2013)
Kew, AU (2007 - 2022)
Parkville, AU (2015 - 2024)

Company Filing History:

Zenyth Operations Pty. Ltd.

The Walter and Eliza Hall Institute of Medical Research

patents

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

29 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12071484 - Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein (2024-08-27),

2. 11345759 - Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies (2022-05-31),

3. 10513560 - Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies (2019-12-24),

4. 10106617 - High affinity antibody antagonists of interleukin-13 receptor alpha 1 (2018-10-23),

5. 9856326 - Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies (2018-01-02),

6. 9856325 - Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies (2018-01-02),

7. 9777062 - High affinity antibody antagonists of interleukin-13 receptor alpha 1 (2017-10-03),

8. 9758585 - Compositions and methods for targeting type 1 interferon producing cells (2017-09-12),

9. 9518127 - Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses (2016-12-13),

10. 9376682 - Method of treating pulmonary disease by administering an antibody to G-CSF (2016-06-28),

11. 9371388 - High affinity antibody antagonists of interleukin-13 receptor alpha 1 (2016-06-21),

12. 9193793 - Antibodies against G-CSFR and uses thereof (2015-11-24),

13. 9085628 - Antibody molecule for human GM-CSF receptor alpha (2015-07-21),

14. 8822644 - Method of treating cancer comprising a VEGF-B antagonist (2014-09-02),

15. 8613925 - Anti-IL-13Rα1 antibodies and their uses thereof (2013-12-24),

Title: The Innovative Journey of Andrew Donald Nash

Introduction: Andrew Donald Nash, a pioneering inventor hailing from Parkville, Australia, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Andrew Nash's latest patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software application designed to streamline communication in the workplace.

Career Highlights: With a career spanning over two decades, Andrew Nash has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various industries.

Collaborations: Throughout his career, Andrew Nash has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Andrew Donald Nash's relentless pursuit of innovation and his passion for creating technology that enhances lives have solidified his position as a prominent figure in the world of inventors. His dedication to pushing the boundaries of what is possible continues to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.